Medical Devices UAE

UAE Hemostats and Sealants Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

UAE Hemostats and Sealants Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UAE · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $32.1 Mn Placeholder estimate
Estimate 2025 $34.7 Mn 0.5% of the global market
Projected 2034 $71.2 Mn 105% Adds $36.4 Mn over 9 forecast years
CAGR 2025–2034 8.3% Faster than 37% of 186 Medical Devices markets here
Key players 5
  • UAE is 0.47% of the global market.
  • In Middle East, the largest is Saudi Arabia at $115.8 Mn.
  • Fastest growing: UAE (this report) at 8.3% a year.
  • UAE ranks 2nd of 2 by size in Middle East.

Market size projection

UAE

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$36.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hemostats and Sealants Market market size by year, UAE
YearMarket sizeChange that yearSince 2025
2024 (estimate) $32.1 Mn — —
2025 (base) $34.7 Mn +$2.7 Mn —
2026 (forecast) $37.6 Mn +$2.9 Mn +8.3%
2027 (forecast) $40.7 Mn +$3.1 Mn +17.3%
2028 (forecast) $44.1 Mn +$3.4 Mn +27%
2029 (forecast) $47.8 Mn +$3.7 Mn +37.6%
2030 (forecast) $51.7 Mn +$4.0 Mn +49%
2031 (forecast) $56.0 Mn +$4.3 Mn +61.4%
2032 (forecast) $60.7 Mn +$4.6 Mn +74.7%
2033 (forecast) $65.7 Mn +$5.0 Mn +89.2%
2034 (forecast) $71.2 Mn +$5.5 Mn +105%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

UAE Hemostats and Sealants Market Analysis at a glance
Market size, 2025$34.7 Mn placeholder estimate
Forecast, 2034$71.2 Mn placeholder estimate
Growth (CAGR), 2025–20348.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledHemostasis and Tissue Sealing Agents
SegmentsProduct, application and end user (see all)
Key playersBaxter International, Johnson & Johnson, BD (Becton, Dickinson), CSL Behring, Integra Life Sciences Corporation (see all)
Regulator in the UAEEDESource: Emirates Drug Establishment. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UAE Hemostats and Sealants Market Analysis Executive Summary

Hemostats and sealants stop bleeding and seal tissue during surgery, using powders, patches and glues.

Key segments of the hemostats and Sealants market include product (Thrombin-Based, Gelatin-Based and Fibrin Sealants) and application (Cardiovascular, General Surgery and Orthopedic).

Bar chart: UAE Hemostats and Sealants market size, 2024–2034, placeholder estimates. $32.1 Mn in 2024, $34.7 Mn in 2025 and $71.2 Mn in 2034, 8.3% CAGR.
UAE Hemostats and Sealants market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UAE Hemostats and Sealants Market Dynamics

Market Growth Drivers

Demand for less invasive surgery, shorter hospital stays, surgeon shortages and improvements in robotics, imaging and AI are driving the hemostats and Sealants market.

Opportunity

Smaller and cheaper systems, outpatient surgery centres and use in emerging markets give the hemostats and Sealants market room to grow.

Market Restraints

High purchase and maintenance costs, training needs and limited proof of better outcomes for some procedures hold back the hemostats and Sealants market.

Competitive Landscape for Hemostats and Sealants Market in the UAE

The hemostats and Sealants market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hemostats and Sealants Market in the UAE

Hemostats and Sealants in the UAE: rules and payment

The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention.⁠[1] Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate.⁠[2]

[1] Emirates Drug Establishment. Checked 14 Nov 2026.

[2] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hemostats and Sealants products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in the UAE.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hemostats and Sealants right now, from free public sources.

Latest research 11 papers since 2021 (worldwide)

  1. Biocompatibility of mussel-inspired water-soluble tissue adhesives. Journal of biomedical materials research. Part A, 2024
  2. Coacervation-triggered hierarchically assembled hydrogels with application as surgical sealant. Biofabrication, 2023
  3. One-Pot Extraction of Bioresources from Human Hair via a Zero-Waste Green Route. ACS omega, 2023
  4. Hemostatic Agents in Orthopedic Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2022
  5. Polymer nanomaterials for use as adjuvant surgical tools. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2023
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hemostats and Sealants in context

The UAE compared

  • Health spending per person: 2,402 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 10 countries we cover in Middle East.[1]
  • Doctors: 2.99 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 4th highest of the 10 countries we cover in Middle East.[2]
  • People aged 65 and over: 1.8% of people (2025). World: 10.4% of people (2025). 9th highest of the 10 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hemostats and Sealants market in the UAE?
Placeholder estimate: about $34.7 Mn in 2025, rising to about $71.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hemostats and Sealants market in the UAE growing?
Placeholder estimate: about 8.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hemostats and Sealants market report cover?
The report splits the market by product (Thrombin-Based, Gelatin-Based, Fibrin Sealants, Synthetic Sealants), application (Cardiovascular, General Surgery, Orthopedic, Neurosurgery) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Hemostats and Sealants market?
Key players include Baxter International, Johnson & Johnson, BD (Becton, Dickinson), CSL Behring and Integra Life Sciences Corporation.
What is driving the Hemostats and Sealants market?
Demand for less invasive surgery, shorter hospital stays, surgeon shortages and improvements in robotics, imaging and AI are driving the hemostats and Sealants market.
Who regulates Hemostats and Sealants in the UAE?
The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention. Source: Emirates Drug Establishment. Checked 14 Nov 2026.
How is healthcare paid for in the UAE?
Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate. Source: Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
How much research is published on Hemostats and Sealants?
PubMed lists 11 papers on Hemostats and Sealants added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in UAE

See all

Related on surgery and wounds and burns

See the topic